INAHTA member agency stories of engaging, adaptable, and impactful HTA.

IF 2.6 4区 医学 Q2 HEALTH CARE SCIENCES & SERVICES International Journal of Technology Assessment in Health Care Pub Date : 2024-12-10 DOI:10.1017/S0266462324004732
Sophie Söderholm Werkö, Sylvie Bouchard, Erni Z Romli, Chunmei Li, Li-Ying Huang, Charlotte Pelekanou, Lauren Elston, Tara Schuller
{"title":"INAHTA member agency stories of engaging, adaptable, and impactful HTA.","authors":"Sophie Söderholm Werkö, Sylvie Bouchard, Erni Z Romli, Chunmei Li, Li-Ying Huang, Charlotte Pelekanou, Lauren Elston, Tara Schuller","doi":"10.1017/S0266462324004732","DOIUrl":null,"url":null,"abstract":"<p><p>Health technology assessment (HTA) agencies assess evidence to support decision making about which technologies to provide and pay for in the health system. HTA impact is understood as the influence that HTA report findings can have in the health system, including impacts on reimbursement decisions, changes to health outcomes, or broader system or societal impacts. The International Network of Agencies for Health Technology Assessment (INAHTA) is a global network of publicly funded HTA agencies. INAHTA's mission, in part, is to advance the impact of HTA to support reimbursement decisions and the optimal use of health system resources. Each year, INAHTA awards the David Hailey Award for Best Impact Story to the member agency that shares the best story, as voted by fellow members, about HTA impact. The impact story sharing program in INAHTA contributes to a deeper understanding of what works well (or not so well) in achieving HTA impact. This paper provides six impact stories from agencies that were finalists for the 2021 and 2022 David Hailey Impact Award for Best Impact Story: the Institut national d'excellence en santé et en services sociaux, the Malaysian Health Technology Assessment Section, Ontario Health, the Center for Drug Evaluation, the National Institute for Health and Care Excellence, and Health Technology Wales. These stories demonstrate that HTA agencies can, in differing ways, effectively support governments in their efforts to place evidence at the centre of decision making.</p>","PeriodicalId":14467,"journal":{"name":"International Journal of Technology Assessment in Health Care","volume":" ","pages":"e4"},"PeriodicalIF":2.6000,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11729482/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Technology Assessment in Health Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1017/S0266462324004732","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Health technology assessment (HTA) agencies assess evidence to support decision making about which technologies to provide and pay for in the health system. HTA impact is understood as the influence that HTA report findings can have in the health system, including impacts on reimbursement decisions, changes to health outcomes, or broader system or societal impacts. The International Network of Agencies for Health Technology Assessment (INAHTA) is a global network of publicly funded HTA agencies. INAHTA's mission, in part, is to advance the impact of HTA to support reimbursement decisions and the optimal use of health system resources. Each year, INAHTA awards the David Hailey Award for Best Impact Story to the member agency that shares the best story, as voted by fellow members, about HTA impact. The impact story sharing program in INAHTA contributes to a deeper understanding of what works well (or not so well) in achieving HTA impact. This paper provides six impact stories from agencies that were finalists for the 2021 and 2022 David Hailey Impact Award for Best Impact Story: the Institut national d'excellence en santé et en services sociaux, the Malaysian Health Technology Assessment Section, Ontario Health, the Center for Drug Evaluation, the National Institute for Health and Care Excellence, and Health Technology Wales. These stories demonstrate that HTA agencies can, in differing ways, effectively support governments in their efforts to place evidence at the centre of decision making.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
INAHTA成员机构的故事参与,适应性强,和有影响力的HTA。
卫生技术评估(HTA)机构评估证据,以支持在卫生系统中提供哪些技术并为其付费的决策。HTA影响被理解为HTA报告结果可能对卫生系统产生的影响,包括对报销决策的影响,对健康结果的改变,或更广泛的系统或社会影响。国际卫生技术评估机构网络(INAHTA)是由公共资助的卫生技术评估机构组成的全球网络。INAHTA的部分使命是促进HTA的影响,以支持报销决策和卫生系统资源的最佳利用。每年,INAHTA都会将“大卫·海利最佳影响力故事奖”颁发给成员机构,这些机构分享了由其他成员投票选出的关于HTA影响力的最佳故事。INAHTA的影响力故事分享项目有助于更深入地了解在实现HTA影响力方面哪些是有效的(或不太有效的)。本文提供了来自2021年和2022年大卫·海利影响力奖最佳影响力故事入选者的六个影响故事:国家卓越医疗服务社会研究所、马来西亚卫生技术评估科、安大略省卫生部、药物评估中心、国家卫生与护理卓越研究所和威尔士卫生技术。这些事例表明,卫生管理局各机构能够以不同的方式有效地支持政府将证据置于决策中心的努力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
International Journal of Technology Assessment in Health Care
International Journal of Technology Assessment in Health Care 医学-公共卫生、环境卫生与职业卫生
CiteScore
4.40
自引率
15.60%
发文量
116
审稿时长
6-12 weeks
期刊介绍: International Journal of Technology Assessment in Health Care serves as a forum for the wide range of health policy makers and professionals interested in the economic, social, ethical, medical and public health implications of health technology. It covers the development, evaluation, diffusion and use of health technology, as well as its impact on the organization and management of health care systems and public health. In addition to general essays and research reports, regular columns on technology assessment reports and thematic sections are published.
期刊最新文献
A MINIMUM DATASET FOR DESTINATION THERAPY WITH LEFT VENTRICULAR ASSIST DEVICE: THE EVIDENCE THAT MATTERS TO DECISION MAKERS. A decision-analytic method to evaluate the cost-effectiveness of remote monitoring technology for chronic depression. Development of a value assessment framework for Health Technology Assessment in rare diseases drugs: insights from a Delphi study in Brazil. Good Practices for Health Technology Assessment Guideline Development: A Report of the Health Technology Assessment International, HTAsiaLink, and ISPOR Special Task Force. How can actuarial science contribute to the field of health technology assessment? An interdisciplinary perspective.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1